
Protesters rally against closure of largest gender-affirming care center for kids in the US
'I hated my body," the nonbinary 16-year-old said. 'I hated looking at it.'
When therapy didn't help, Pitchenik, who uses the pronoun they, started going to the Center for Transyouth Health and Development at Children's Hospital Los Angeles, the country's biggest public provider of gender-affirming care for children and teens. It changed their life.
But in response to the Trump administration's threat to cut federal funds to places that offer gender-affirming care to minors, the center will be closing its doors July 22. Pitchenik has been among the scores of protesters who have demonstrated regularly outside the hospital to keep it open.
'Trans kids are done being quiet. Trans kids are done being polite, and trans kids are done begging for the bare minimum, begging for the chance to grow up, to have a future, to be loved by others when sometimes we can't even love ourselves,' Pitchenik said, prompting cheers from dozens of protesters during a recent demonstration.
They went to the center for six years.
'There's a lot of bigotry and just hate all around, and having somebody who is trained specifically to speak with you, because there's not a lot of people that know what it's like, it meant the world,' they told The Associated Press.
The center's legacy
In operation for three decades, the facility is among the longest-running trans youth centers in the country and has served thousands of young people on public insurance.
Patients who haven't gone through puberty yet receive counseling, which continues throughout the care process. For some patients, the next step is puberty blockers; for others, it's also hormone replacement therapy. Surgeries are rarely offered to minors.
'I'm one of the lucky ones,' said Pitchenik, who received hormone blockers after a lengthy process. 'I learned how to not only survive but how to thrive in my own body because of the lifesaving health care provided to me right here at Children's Hospital Los Angeles.'
Many families are now scrambling to find care among a patchwork of private and public providers that are already stretched thin. It's not just patient care, but research development that's ending.
'It is a disappointment to see this abrupt closure disrupting the care that trans youth receive. But it's also a stain on their legacy,' said Maria Do, community mobilization manager at the Los Angeles LGBT Center. 'I think it showcases that they're quick to abandon our most vulnerable members.'
The closure comes weeks after the Supreme Court upheld Tennessee's ban on gender-affirming care for minors, amid other efforts by the federal government to regulate the lives of transgender people.
The hospital initially backed off its plans to close after it announced them in February, spurring demonstrations, but later doubled back.
The center said in a statement that 'despite this deeply held commitment to supporting LA's gender-diverse community, the hospital has been left with no viable path forward' to stay open.
'Center team members were heartbroken to learn of the decision from hospital leaders, who emphasized that it was not made lightly, but followed a thorough legal and financial assessment of the increasingly severe impacts of recent administrative actions and proposed policies,' the statement said.
California Attorney General Rob Bonta has warned that by closing the center, the hospital is violating state antidiscrimination laws, but his office hasn't taken any further actions. Bonta and attorney generals from 22 other states sued the Trump administration over the executive order in February.
'The Trump administration's relentless assault on transgender adolescents is nothing short of an all-out war to strip away LGBTQ+ rights.' Bonta told the AP in an email. 'The Administration's harmful attacks are hurting California's transgender community by seeking to scare doctors and hospitals from providing nondiscriminatory healthcare. The bottom line is: This care remains legal in California.'
LGBTQ+ protesters and health care workers offer visibility
Still wearing scrubs, Jack Brenner, joined protesters after a long shift as a nurse in the hospital's emergency room, addressing the crowd with a megaphone while choking back tears.
'Our visibility is so important for our youth,' Brenner said, looking out at a cluster of protesters raising signs and waving trans pride flags. 'To see that there is a future, and that there is a way to grow up and to be your authentic self.'
Brenner, who uses the pronoun they, didn't see people who looked like them growing up or understand what being trans meant until their mid-20s.
'It's something I definitely didn't have a language for when I was a kid, and I didn't know what the source of my pain and suffering was, and now looking back, so many things are sliding into place," Brenner said. 'I'm realizing how much gender dysphoria was a source of my pain.'
Trans children and teens are at increased risk of death by suicide, according to a 2024 study from the Centers for Disease Control and Prevention.
Brenner described encountering young patients in the emergency room who are trans or otherwise on the gender-nonconforming spectrum and 'at the peak of a mental health crisis.' Brenner wears a lanyard teeming with colorful pins emblazoned with the words 'they/them' to signal their gender identity.
'I see the change in kids' eyes, little glints of recognition, that I am a trans adult and that there is a future,' Brenner said. 'I've seen kids light up when they recognize something of themselves in me. And that is so meaningful that I can provide that.'
Beth Hossfeld, a marriage and family therapist, and a grandmother to an 11- and 13-year-old who received care at the center, called the closure 'patient abandonment.'
'It's a political decision, not a medical one, and that's disturbing to me,' she said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
8 minutes ago
- The Independent
Faith-based activist groups celebrate after Costco bails on selling abortion pill
Costco has opted not to dispense abortion pills after receiving demands from activists on both sides of the issue — and faith-based groups are celebrating the move. Last year, New York City Comptroller Brad Lander urged the retail giant to get a certification to be able to dispense mifepristone — one drug in a two-drug regimen for medication abortions — at its pharmacies. The following month a religious coalition pleaded with Costco not to sell the termination pill. The FDA allows only certified prescribers to dispense mifepristone. Costco chose to forego pursuing this certification, the company said in a statement to Reuters emphasizing the decision was based on a lack of consumer demand. "Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers,' the company said. Bloomberg first reported Costco's decision. The Independent has reached out to Costco for more information about its decision. Representatives on both sides of the abortion debate have battled over Costco's position in the form of letters. Last July, Lander penned a letter to CEO Ron Vachris demanding the retailer 'immediately take the necessary steps to receive certification' to sell mifepristone, following in the steps of CVS and Walgreens. The comptroller also wrote letters to the leaders of Walmart, Kroger, Albertsons, and McKesson. 'By failing to become certified mifepristone dispensers, these pharmacy giants put both women's reproductive health care and investors' money at risk,' he said in a statement at the time. In August 2024, a coalition of religious activists wrote to Vachris, urging Costco to 'continue its current practice of not dispensing the abortion drug mifepristone.' The group argued that dispensing the drug will reduce demand for the diapers and formula that the store sells and worsen the 'the crisis of record low birth rates.' The letter also alleged the pill poses 'serious health risks.' The FDA first approved the drug in 2000 to end pregnancy through 10 weeks of gestation, but anti-abortion activists have recently challenged its safety and FDA approval. Last year, the Supreme Court unanimously ruled to preserve access to the crucial drug, as nearly two-thirds of all abortions in the U.S. — 63 percent — are medication abortions, according to the Guttmacher Institute. 'Costco's decision to refuse to dispense mifepristone is disappointing and short-sighted,' a spokesperson for Lander told The Independent in a statement. Failure to provide access to proven safe and FDA-approved medication under the guise of 'weak demand' risks isolating customers and undermines the company's credibility. Putting customer needs before political ideology must remain Costco's priority.' Faith-based activists have celebrated the decision. 'We applaud Costco for doing the right thing by its shareholders and resisting activist calls to sell abortion drugs,' Alliance Defending Freedom Legal Counsel Michael Ross said in a statement Thursday. 'They have nothing to gain and much to lose by becoming abortion dispensaries.' 'We have this momentum,' Tim Schwarzenberger, director of corporate engagement at Inspire Investing, the world's largest faith-based ETF provider, told Bloomberg. 'Now there is a chance to turn to some of the other retailers.' 'We are so grateful that Costco—a company that serves families, especially large ones—has decided to remain a wholesale store, not become an abortion facility,' Mary Szoch, director of the Center for Human Dignity at evangelical think-tank Family Research Council, said in a statement on X. 'What a win for America! Great job, @Costco!" CVS and Walgreens, which both dispense the drug, have stood by their decisions in the wake of Costco's announcement. 'We have a long history of supporting and advancing women's health and we remain focused on meeting their unique health needs. This includes providing access to safe, legal, and evidence-based reproductive health services,' CVS told The Independent in a statement, noting that the company fills prescriptions in states where it's legal. Walgreens declined to comment. Its website states: "The U.S. Supreme Court's ruling on mifepristone access allows Walgreens to continue to dispense mifepristone under the FDA guidelines.' The abortion landscape has been complicated after the fall of Roe v. Wade in 2022. In January 2023, the FDA removed some restrictions around accessing mifepristone and added the pharmacy certification. Individuals living in states that have banned the procedure cannot access the drug at pharmacies; 12 states have total abortion bans, according to Guttmacher Institute. The 2022 Supreme Court ruling overturning Roe has opened the door for abortion opponents to argue fresh legal challenges. Earlier this year, anti-abortion activists pushed a report by right-wing think tank Ethics and Public Policy Center claiming serious complications from mifepristone use were 22 times higher than previously reported. Critics blasted the report as 'bogus.'


The Independent
8 minutes ago
- The Independent
4th person dies after a Legionnaires' disease outbreak sickens dozens in New York City
A fourth person has died in connection with a Legionnaires' disease outbreak in New York City, health officials disclosed Thursday as they revealed that some cooling towers that tested positive for the bacteria are in city-run buildings. The outbreak in Central Harlem has sickened dozens since it began in late July. Seventeen people were hospitalized as of Thursday, according to the health department. The bacteria that causes Legionnaires' disease had been discovered in 12 cooling towers on 10 buildings, including a city-run hospital and sexual health clinic, health officials said. Remediation efforts have been completed on 11 of the cooling towers, with the final tower's remediation required to be completed Friday. Legionnaires' disease is a type of pneumonia that is caused by Legionella bacteria, which grow in warm water and spread through building water systems. The city's outbreak has been linked to cooling towers, which use water and a fan to cool buildings. People usually develop symptoms — a cough, fever, headaches, muscle aches and shortness of breath — between two days to two weeks after exposure to the bacteria, according to the U.S. Centers for Disease Control and Prevention. Dr. Michelle Morse, the city's acting health commissioner, said new cases in the Central Harlem outbreak have begun to decline 'which indicates that the sources of the bacteria have been contained.' She urged people who live or work in the area to contact a health care provider if they develop flu-like symptoms.


Daily Mail
39 minutes ago
- Daily Mail
New antibiotics capable of killing drug-resistant gonorrhoea are developed... by AI
New antibiotics capable of killing drug-resistant gonorrhoea have been developed by AI. Experts believe that Artificial Intelligence could signify a 'second golden age' of antibiotic discovery, after creating two drugs that could be capable of killing superbugs such as gonorrhea and MRSA. Led by Professor James Collins at the Massachusetts Institute of Technology (MIT), a specialist research team used generative AI algorithms to interrogate 36million compounds. The experts then trained the AI to help it learn how bacteria was affected by different molecular structures built of atoms in order to design new antibiotics. In order to do this, they gave it the chemical structure of known compounds and data on their ability to hinder the growth of different bacteria species. Throughout the study, published in the journal Cell, anything too similar to the current antibiotics available, or with the potential to be toxic to human beings, was eradicated. Scientists also had to ensure that the system was indeed creating medicine, rather than soap. Two approaches were then attempted to help design antibiotics with AI - the first searching through millions of chemical fragments, while the other allowed AI to control the process entirely. The result was innovative AI-generated drugs for both the sexually transmitted infection and possibly life-threatening MRSA (methicillin-resistant Staphylococcus aureus). Both were found to be capable of killing the superbugs in laboratory and animal tests. It marks a significant move in the use of AI among researchers hoping to combat the rise in deaths caused by an overuse of antibiotics. The bacteria-fighting medicines are crucial for clearing infections and preventing life-threatening complications. However, hard-to-treat cases are on the rise as the bacteria that cause them are becoming increasingly impervious to the drugs. At least one million annual deaths due to antibiotic resistance have been recorded globally since 1990, according to the University of Oxford. Over the past decade, the NHS has made a concerted effort to reduce the number of antibiotic prescriptions given to patients, in order to slow the spread of superbugs. Yet 37 million prescriptions were written in the UK in 2023, compared to 36 million in 2022 and 31 million in 2020, official figures show. However, clinical trials and a further refinement of the possible drugs, estimated to take between one and two years, will be required before the drugs can be prescribed. WHAT IS ANTIBIOTIC RESISTANCE? Bacteria can become drug resistant when people take incorrect doses of antibiotics or if they are given out unnecessarily. The World Health Organization (WHO) has previously warned if nothing is done the world is heading for a 'post-antibiotic' era. Bacteria can become drug resistant when people take incorrect doses of antibiotics or if they are given out unnecessarily. Former chief medical officer Dame Sally Davies claimed in 2016 that the threat of antibiotic resistance is as severe as terrorism. Dr Andrew Edwards, from the Fleming Initiative and Imperial College London, told the BBC that the work has 'enormous potential' and indicates a 'novel approach to identifying new antibiotics'. Meanwhile, Professor Chris Dawson, from the University of Warwick, said that the drugs could mark a 'significant step forward as a tool for antibiotic discovery'. However, Professor Collins warned that 'better models' are still required for AI to truly help tackle drug-resistant infections. Other concerns raised by medical experts included how complex the AI-designs are to manufacture, with just two drugs created out of 80 initial designs. Meanwhile, a new antibiotic designed to treat drug-resistant infections would ideally be used as little as possible in order to ensure its success. This, therefore, raises questions about the likelihood of a commercial profit being possible. In 2024, an estimated 71,802 people were diagnosed with gonorrhoea, according to government figures. Meanwhile, 910 cases of MRSA were recorded across England from 2023 to 2024, marking an increase of 15.6 per cent from 2022 to 2023. While MRSA can live harmlessly on the skin, the bacteria has the potential to become deadly if it enters the body.